Polycystins and intercellular mechanotransduction: A precise dosage of polycystin 2 is necessary for alpha-actinin reinforcement of junctions upon mechanical stimulation-Reference-Cited by-同舟云学术

Polycystins and intercellular mechanotransduction: A precise dosage of polycystin 2 is necessary for alpha-actinin reinforcement of junctions upon mechanical stimulation

Published:2016-10 Issue:1 Volume:348 Page:23-35
ISSN:0014-4827
Container-title:Experimental Cell Research
language:en
Short-container-title:Experimental Cell Research

Author:

Bhoonderowa Laxsoomee,Hameurlaine Fatima,Arbabian Atousa,Faqir Fahima,Amblard François,Coscoy Sylvie

Funder

Institut Curie

Centre National de la Recherche Scientifique

Publisher

Elsevier BV

Subject

Cell Biology

Reference88 articles.

1. Regulation of cadherin-mediated adhesion in morphogenesis;Gumbiner;Nat. Rev. Mol. Cell Biol.,2005

2. Alpha-catenin is a molecular switch that binds E-cadherin-beta-catenin and regulates actin-filament assembly;Drees;Cell,2005

3. Myosin II isoforms identify distinct functional modules that support integrity of the epithelial zonula adherens;Smutny;Nat. Cell Biol.,2010

4. Vinculin potentiates E-cadherin mechanosensing and is recruited to actin-anchored sites within adherens junctions in a myosin II-dependent manner;le Duc;J. Cell Biol.,2010

5. alpha-Catenin as a tension transducer that induces adherens junction development;Yonemura;Nat. Cell Biol.,2010

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decoupling shear stress and pressure effects in the biomechanics of autosomal dominant polycystic kidney disease using a perfused kidney-on-chip;2024-06-22

2. Activation of Piezo1 Inhibits Kidney Cystogenesis;2024-05-14

3. Functions of actin‐binding proteins in cilia structure remodeling and signaling;Biology of the Cell;2023-08-17

4. Anoctamin 1 Inhibition Suppresses Cystogenesis by Enhancing Ciliogenesis and the Ciliary Dosage of Polycystins;Frontiers in Bioscience-Landmark;2022-07-08

5. PATHOGENESIS AND THERAPY IN POLYCYSTIC KIDNEY DISEASES;ACTA MEDICA MEDITERR;2022